United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 0.25 mg - xanax is indicated for the: xanax is contraindicated in patients: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including xanax, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/research/pregnancyregistry/. neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.8) and clinical considerations)] . available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see data ). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adve

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 0.5 mg - xanax xr is indicated for the treatment of panic disorder with or without agoraphobia, in adults. xanax xr is contraindicated in patients: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including xanax xr, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/. neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.8), and clinical considerations)] . available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see data ). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pre

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 0.5 mg - alprazolam - for the treatment of anxiety and anxiety associated with depression.treatment of panic disorder with or without phobic avoidance

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 1 mg - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 2 mg - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 0.5 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression.treatment of panic disorder with or without phobic avoidance

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 1 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 2 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance

United States - English - NLM (National Library of Medicine)

direct_rx - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - anxiety disorders alprazolam tablets are indicated for the management of anxiety disorder (a condition corresponding most closely to the apa diagnostic and statistical manual [dsm-iii-r] diagnosis of generalized anxiety disorder) or the short-term relief of symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry (apprehensive expectation) about two or more life circumstances, for a period of 6 months or longer, during which the person has been bothered more days than not by these concerns. at least 6 of the following 18 symptoms are often present in these patients: motor tension (trembling, twitching, or feeling shaky; muscle tension, aches, or soreness; restlessness; easy fatigability); autonomic hyperactivity (shortness of breath or smothering sensations; palpitations or accelerated heart rate; sweating, or cold clammy hands; dry mouth

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - alprazolam -